Buspirone Hydrochloride
Product Images NDC 45865-887

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 45865-887). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (887)

This is a medication description for Buspirone HCL L, which comes in the form of 15mg tablets. It is indicated for the treatment of anxiety disorders and should be taken twice daily at the recommended dosage. Possible side effects include dizziness and drowsiness, which may be exacerbated by alcohol and grapefruit consumption.*

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

15 mg (the Entire Tablet) (Image 02)

FDA Label Image

10 mg (two-thirds Of A Tablet) (Image 03)

FDA Label Image

7.5 mg (one-half Of A Tablet) (Image 04)

FDA Label Image

5 mg (one-third Of A Tablet) (Image 05)

FDA Label Image

Break Tablet 15 mg (Image 06)

FDA Label Image

30 mg (the Entire Tablet) (Image 07)

FDA Label Image

20 mg (two-thirds Of A Tablet) (Image 08)

FDA Label Image

15 mg (one-half Of A Tablet) (Image 09)

FDA Label Image

10 mg (one-third Of A Tablet) (Image 10)

FDA Label Image

Break Tablet 30 mg (Image 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.